Dermatomyositis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
[[Creatine kinase]] (CK) and [[aldolase]] levels may be increased, which would be indicative of muscle damage. | [[Creatine kinase]] (CK) and [[aldolase]] levels may be increased, which would be indicative of muscle damage. | ||
| Line 19: | Line 18: | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
Latest revision as of 13:54, 14 June 2016
|
Dermatomyositis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatomyositis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Dermatomyositis laboratory findings |
|
Risk calculators and risk factors for Dermatomyositis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Creatine kinase (CK) and aldolase levels may be increased, which would be indicative of muscle damage.
Laboratory Findings
Blood tests such as creatine kinase (CK) and aldolase may help diagnose dematomyositis. Patients with dematomyositis may show increased CK and aldolase levels, indicating muscle damage.